Abcombi Biosciences
OverviewSuggest Edit
Abcombi Biosciences (ABI) is a preclinical-stage biotechnology company that focuses on the vaccine and therapeutic development area. It provides a biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus. In addition, the company specializes in bioinformatics, polysaccharide conjugate vaccine manufacturing, and RNA-based therapy for treating influenza infections.
| Type | Private | |
| Founded | 2015 | |
| Website | abcombibio.com |
Latest Updates
| Employees (est.) (Feb 2021) | 3 | |
| Cybersecurity rating | A | More |
Abcombi Biosciences Financials and Metrics
Summary Metrics
Founding Date | 2015 |
Abcombi Biosciences Cybersecurity Score
Abcombi Biosciences Online and Social Media Presence
Abcombi Biosciences's Trends
Abcombi Biosciences Frequently Asked Questions
When was Abcombi Biosciences founded?
Abcombi Biosciences was founded in 2015.
How many employees does Abcombi Biosciences have?
Abcombi Biosciences has 3 employees.
Who are Abcombi Biosciences competitors?
Competitors of Abcombi Biosciences include Triumvira, Tikomed and Sanofi.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies